Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Market Entry
Nov 20 2025
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers in 2026
Explore how FDA Import Alerts block non-compliant drugs, focusing on the 2025 GLP-1 crackdown, Green List requirements, and financial penalties for manufacturers.
